Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention, Atlanta, Georgia.
Fertil Steril. 2014 Apr;101(4):1019-25. doi: 10.1016/j.fertnstert.2013.12.030. Epub 2014 Jan 30.
To examine differences in maternal characteristics and pregnancy outcomes between women with ovulatory dysfunction (OD) and women with tubal obstruction (TO) who underwent assisted reproductive technology (ART).
Retrospective cohort study.
Centers for Disease Control and Prevention.
PATIENT(S): Exposed and nonexposed groups were selected from the 2000-2006 National ART Surveillance System linked with live-birth certificates from three states: Florida, Massachusetts, and Michigan.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Maternal characteristics and pregnancy outcomes, including newborn's health status right after delivery (Apgar score, <7 vs. ≥ 7) as the study outcome of interest, were assessed among women with OD/polycystic ovary syndrome (PCOS) and TO who used ART.
RESULT(S): A significantly higher prevalence of women with OD/PCOS were younger (<35 years of age; 65.7% vs. 48.9%), were white (85.4% vs. 74.4%), had higher education (29.4% vs. 15.6%), and experienced diabetes (8.8% vs. 5.3%) compared with those having TO. The odds of having a lower (<7) Apgar score at 5 minutes were almost twice as high among newborns of women with OD/PCOS compared with those with TO (crude odds ratio, 1.86; 95% confidence interval [CI], 1.31, 2.64; adjusted odds ratio, 1.90; 95% CI, 1.30, 2.77).
CONCLUSION(S): Women with OD/PCOS who underwent ART have different characteristics and health issues (higher prevalence of diabetes) and infant outcomes (lower Apgar score) compared with women with TO.
研究行辅助生殖技术(ART)的排卵功能障碍(OD)和输卵管阻塞(TO)女性在母体特征和妊娠结局方面的差异。
回顾性队列研究。
疾病控制和预防中心。
从佛罗里达州、马萨诸塞州和密歇根州的三个州的活产证明书中,选取暴露组和非暴露组,纳入 2000-2006 年全国 ART 监测系统中的患者。
无。
评估行 ART 的 OD/多囊卵巢综合征(PCOS)和 TO 女性的母体特征和妊娠结局,包括新生儿出生时的健康状况(阿普加评分,<7 与≥7)作为研究的主要结局。
OD/PCOS 组年轻(<35 岁;65.7%比 48.9%)、白人(85.4%比 74.4%)、受教育程度高(29.4%比 15.6%)、患糖尿病(8.8%比 5.3%)的比例显著高于 TO 组。与 TO 组相比,OD/PCOS 组新生儿的阿普加评分<5 分钟的可能性几乎高出两倍(粗比值比,1.86;95%置信区间[CI],1.31,2.64;调整比值比,1.90;95%CI,1.30,2.77)。
与 TO 组相比,行 ART 的 OD/PCOS 女性具有不同的特征和健康问题(糖尿病患病率较高)以及婴儿结局(阿普加评分较低)。